The most prominent symptoms of COPD are chronic and systemic inflammation in the lungs. Stem cell therapy is considered a COPD treatment breakthrough because it not only eases the symptoms of COPD but also targets the root cause of it. The cells improve pulmonary function and reduce inflammation by modulating the immune system.
Pre-clinical studies and research on stem cells for COPD show some promising findings. They reveal that human umbilical cord tissue-derived stem cells aid in the regeneration of alveolar-like structures, reduction of inflammatory responses, and repair of emphysematous lungs. Introducing stem cells into the body signals the cells to produce molecules such as extracellular matrix proteins, peptides, and other growth factors that support tissue repair and regeneration. Further studies also reveal that there is a reduction of the inflammatory marker, which is the C-reactive protein.
Also, the safety and effectiveness of COPD treatment using stem cells are high and the responses from our patients are satisfactory. However, it is important for every COPD patient to understand that efficacy and success are tied up to multiple factors such as age, weight, pre-existing ailment, severity of the condition, patient lifestyle, and others.